Click here to listen to IPEC-Americas Vice Chair for Science and Regulatory Policy, David R. Schoneker, discuss the TI02 issue.
IPEC-Americas is delighted to announce its official 30th Anniversary on June 18th, 2021. #excipientexperts
The Food and Drug Administration (FDA or Agency) just announced today the availability of a draft guidance for industry entitled “Q3D(R2)—Guideline for Elemental Impurities.
Workshops: September 27
Conference & Expo: September 28-29
An overview of IPEC-Americas activities for the year 2020 has now been published!
The IPEC Federation announces the availability of a new position paper, "Pharmaceutical lactose used in oral preparations is a low-risk excipient".